Gulf Pharmaceutical Industries P.S.C. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was AED 365.7 million compared to AED 186.9 million a year ago. Net income was AED 53.3 million compared to net loss of AED 15.6 million a year ago. Basic earnings per share from continuing operations was AED 0.028. Basic earnings per share was AED 0.046 compared to basic loss per share of AED 0.016 a year ago. For the nine months, sales was AED 752.4 million compared to AED 461 million a year ago. Net income was AED 103.2 million compared to net loss of AED 98.8 million a year ago. Basic earnings per share was AED 0.089 compared to basic loss per share of AED 0.096 a year ago.